Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-stroke fatigue modafinil trial
ACTRN12618000602224Phase 3Recruiting
- Sponsor
- Florey Institute of Neuroscience and Mental Health
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-stroke fatigue (PSF) comparing Modafinil with Placebo (2 arms). Primary endpoint: Change in quality of life using SF-36 with 10-point improvement threshold. Started Jun 2018; status: recruiting.
02
Drugs
modafinil
03
Conditions
post-stroke fatigue (PSF)
Beyond the preview
Go deeper on ACTRN12618000602224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000602224.